Assessment of Parkinson's disease with imaging.
In this article the value of structural and functional imaging in aiding the diagnosis and management of Parkinson's disease is reviewed. The underlying pathological mechanisms leading to tremor, coexistent dementia and depression in PD are considered and the role of imaging as a biomarker for testing neuroprotective agents debated.
Brooks
David J
DJ
MRC Clinical Sciences Centre and Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, UK.
D002395:Catecholamines / Q000378:metabolism; D003704:Dementia / Q000150:complications; D003863:Depression / Q000150:complications; D003952:Diagnostic Imaging / Q000379:methods*; D006801:Humans; D017063:Outcome Assessment, Health Care; D010300:Parkinson Disease / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D014202:Tremor / Q000150:complications
D002395:Catecholamines